Shandong Weifang Pharmaceutical Factory Co., Ltd.

Shandong Weifang Pharmaceutical Factory Co., Ltd., was established in 1966. The company covers an area of 16, 500 sqm, including construction area of 14, 600 sqm. She owns 382 employees, among them are 112 technicians, 11 licensed pharmacists.

Owns 5 modern GMP pharmaceutical workshops specializing in manufacturing water injectables, sterile powder injections, tablets, capsules and APIs. These 5 workshops all have passed the certification of Chinese GMP. The Captopril API workshop has been approved by US FDA in 1998 and passed the cGMP reinspection in 2004. She is the only one who has passed FDA inspection in China. We have also obtained COS of Europe for Captopril API in 2007.

We manufacture 5 series of products including 74 varieties and 116 specifications. The annual productivity is: 100 millions of water injectables, 52 millions of powder injections, 500 millions of tablets, 1, 500 millions of capsules, and 150 tons of raw materials. Our main products including APIs such as Captopril, Enalapril, Lisinopril, Gemfibrozil, Lomustine, Hydralazine Hydrochloride, Acetylglutamine and other finished formulations.

We have set up business relationships with foreign partners for APIs including Captopril, Enalapril, Lisinopril, Hydralazine Hydrochloride and Gemfibrozil etc. As well as the channel and business on finished formulation. These foreign partners include: Rolabo, Sanofi-synthelabo, Teva pharmaceutical, Helm AG, Midas Pharmaceutical, Aceto Ltd. Hikma Pharmaceutical, Biogal Pharmaceutical, West-ward Pharmaceuticals, LCM S. P. A., Zeta Pharmaceutical and Worwag GmbH, etc.